Anti-depressant therapy and cancer risk: A nested case-control study
- 1 August 2015
- journal article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 25 (8) , 1147-1157
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Use of antidepressants and the risk of breast cancer: a meta-analysisBreast Cancer Research and Treatment, 2012
- A population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: The impact of duration of use, cumulative dose and latencyBMC Medicine, 2010
- Colorectal cancer risk in relation to antidepressant medication useInternational Journal of Cancer, 2010
- Antidepressant use and colorectal cancer risk: a Danish population-based case–control studyBritish Journal of Cancer, 2010
- Antidepressant use and colorectal cancer riskPharmacoepidemiology and Drug Safety, 2009
- SSRI use and breast cancer risk by hormone receptor statusBreast Cancer Research and Treatment, 2007
- Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cellsEuropean Journal of Pharmacology, 2006
- Use of Selective Serotonin Reuptake Inhibitors and the Risk of Breast CancerAmerican Journal of Epidemiology, 2005
- Antidepressant Medication Use and Breast Cancer RiskAmerican Journal of Epidemiology, 2000
- Evidence that the antiestrogen binding site is a histamine or histamine-like receptorBiochemical and Biophysical Research Communications, 1985